Home> Products> silodosia 8d

{ "products": [ { "_id": "6666ee5d04b14f2344408bd4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA SF ", "description": "SILODOSIA SF \nSilodosin (8mg) & Solifenacin (5mg)\nSilodosia SF is a medication that combines Silodosin (8mg) and Solifenacin (5mg) in a single formulation. Silodosin is an alpha-blocker that relaxes muscles in the prostate and bladder neck, helping to relieve symptoms of enlarged prostate (benign prostatic hyperplasia - BPH) such as difficulty urinating. Solifenacin is an antimuscarinic agent that reduces bladder muscle spasms, helping to control overactive bladder symptoms like frequent or urgent urination.\n\nKey Features:\n\nCombination of Silodosin (8mg) and Solifenacin (5mg)\nAlpha-blocker and antimuscarinic properties\nRelieves BPH symptoms like difficulty urinating\nControls overactive bladder symptoms like frequent or urgent urination\nUsage and Dosage:\n\nTake Silodosia SF as prescribed by your healthcare provider.\nTypically taken once daily, with or without food.\nSwallow the tablet whole, without crushing or chewing.\nSide Effects:\n\nCommon side effects may include dizziness, headache, dry mouth, and constipation.\nNotify your doctor if these side effects persist or worsen.\nSeek immediate medical attention if you experience severe dizziness, fainting, or allergic reactions.\nPrecautions:\n\nInform your doctor about any medical conditions or medications you are taking.\nAvoid activities requiring mental alertness until you know how Silodosia SF affects you.\nDo not take Silodosia SF if you have certain urinary or gastric conditions without consulting your doctor.\nStorage:\n\nStore Silodosia SF at room temperature, away from moisture and heat.\nKeep out of reach of children and pets.\nAlways follow your healthcare provider's instructions for the safest and most effective use of Silodosia SF. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/silodosia-sf-133508", "price": 399.0, "discountamount": 120.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "pets", "heat", "Usage", "Email", "ORDER", "reach", "tablet", "Dosage", "safest", "doctor", "muscles", "urinary", "Storage", "moisture", "Controls", "fainting", "children", "headache", "frequent", "WhatsApp", "Silodosin", "urinating", "dry mouth", "medication", "difficulty", "activities", "information", "Combination", "Solifenacin", "Precautions", "constipation", "instructions", "sterispharma", "sterisonline", "Key Features", "bladder neck", "BPH symptoms", "SILODOSIA SF", "effective use", "alpha-blocker", "urgent urination", "severe dizziness", "room temperature", "mental alertness", "enlarged prostate", "allergic reactions", "gastric conditions", "single formulation", "medical conditions", "healthcare provider", "Common side effects", "antimuscarinic agent", "bladder muscle spasms", "antimuscarinic properties", "overactive bladder symptoms", "immediate medical attention", "benign prostatic hyperplasia" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1695, "imageuri": "https://productimages.withfloats.com/actual/667d393bba7e6420d2a5315b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d393bba7e6420d2a5315b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T12:15:25.248Z", "updatedon": "2026-03-17T06:28:22.914Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/silodosia-sf-/1695", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SILODOSIA SF ", "category": "UROLOGYRANGE", "tags": [ "SILODOSIA SF", "Silodosin (8mg)", "Solifenacin 5mg price", "Solifenacin (5mg)", "Solifenacin (5mg)", "Solifenacin (5mg)", "Solifenacin (5mg)" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666ebde899bdd18a0443e2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA M 50 KIT ", "description": "SILODOSIA M 50 KIT \nCombipack of Mirabegron 50 mg & Silodosin 8 mg\nSioldosia M 50 Kit is a combination pack containing Mirabegron 50 mg and Silodosin 8 mg. It is used to treat symptoms of overactive bladder (OAB) such as urinary urgency, frequency, and incontinence. Mirabegron works by relaxing the bladder muscles, while Silodosin relaxes the muscles in the prostate and bladder neck, improving urine flow. This combination provides effective relief for patients with OAB and related urinary symptoms.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/silodosia-m-50-kit-134233", "price": 570.0, "discountamount": 171.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "OAB", "Email", "ORDER", "WhatsApp", "patients", "prostate", "Combipack", "frequency", "Silodosin", "urine flow", "information", "sterispharma", "incontinence", "sterisonline", "bladder neck", "bladder muscles", "urinary urgency", "combination pack", "effective relief", "Mirabegron 50 mg", "overactive bladder", "SILODOSIA M 50 KIT", "Sioldosia M 50 Kit", "related urinary symptoms" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1694, "imageuri": "https://productimages.withfloats.com/actual/667d3972c303c6d6ad13771f.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3972c303c6d6ad13771f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T12:04:46.544Z", "updatedon": "2026-03-17T06:27:15.966Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//silodosia-m-50-kit-/1694", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SILODOSIA M 50 KIT ", "category": "UROLOGYRANGE", "tags": [ "SILODOSIA M 50 KIT", "Combipack of Mirabegron 50 mg", "Silodosin 8 mg side effects", "Silodosin 8 mg", "Silodosin 8 mg", "Silodosin 8 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666eb4e14f4ba0ae8765e21", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA M 25 KIT ", "description": "SILODOSIA M 25 KIT \nCombipack of Mirabegron Extended Release 25 mg & Silodosin 8 mg\nSilodosia M 25 Kit is a combination pack containing Mirabegron Extended Release 25 mg and Silodosin 8 mg. Mirabegron is a beta-3 adrenergic agonist used to treat overactive bladder symptoms like frequent urination, urgency, and urinary incontinence. It works by relaxing the bladder muscles, increasing bladder capacity, and reducing the frequency of bathroom visits.\n\nSilodosin, on the other hand, is an alpha-1 adrenergic receptor antagonist used to improve symptoms of benign prostatic hyperplasia (BPH) in men. It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.\n\nThis combination pack provides dual benefits for patients with overactive bladder symptoms and BPH, offering relief from urinary symptoms like urgency, frequency, nocturia, weak stream, and incomplete bladder emptying. It is important to follow the dosage and instructions provided by your healthcare provider for optimal results and safety. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/silodosia-m-25-kit-134258\n\n\n\n\n\n\n", "price": 470.0, "discountamount": 141.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BPH", "men", "Call", "Email", "ORDER", "relief", "safety", "dosage", "urgency", "WhatsApp", "nocturia", "patients", "prostate", "Combipack", "frequency", "other hand", "weak stream", "information", "instructions", "sterispharma", "bladder neck", "sterisonline", "dual benefits", "Silodosin 8 mg", "optimal results", "bathroom visits", "bladder muscles", "combination pack", "urinary symptoms", "bladder capacity", "frequent urination", "SILODOSIA M 25 KIT", "healthcare provider", "urinary incontinence", "beta-3 adrenergic agonist", "overactive bladder symptoms", "Mirabegron Extended Release", "incomplete bladder emptying", "benign prostatic hyperplasia", "alpha-1 adrenergic receptor antagonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1693, "imageuri": "https://productimages.withfloats.com/actual/667d39a0c303c6d6ad13773b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d39a0c303c6d6ad13773b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T12:02:22.905Z", "updatedon": "2026-03-17T06:25:55.498Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//silodosia-m-25-kit-/1693", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SILODOSIA M 25 KIT ", "category": "UROLOGYRANGE", "tags": [ "SILODOSIA M 25 KIT", "Combipack of Mirabegron Extended Release 25 mg", "Silodosin 8 mg side effects", "Silodosin 8 mg dosage", "Silodosin 8 mg tablet", "Silodosin 8 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666e9b000e7d2232cab24c3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA 8", "description": "SILODOSIA 8\nSilodosin (8mg)\nSilodosia 8 contains Silodosin, an alpha-1 adrenergic receptor antagonist used to treat symptoms of benign prostatic hyperplasia (BPH). Silodosin (8mg) helps relax muscles in the prostate and bladder neck, improving urine flow and reducing urinary symptoms like frequent urination, urgency, and difficulty starting urination. It is taken orally as directed by a healthcare professional, usually once daily with food to minimize the risk of dizziness. Common side effects may include dizziness, headache, drowsiness, and nasal congestion. It's important to follow your doctor's instructions and report any severe or persistent side effects promptly.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/silodosia-8-133505", "price": 233.0, "discountamount": 70.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BPH", "risk", "food", "Email", "ORDER", "severe", "doctor", "urgency", "muscles", "prostate", "headache", "WhatsApp", "Silodosin", "dizziness", "SILODOSIA", "drowsiness", "urine flow", "difficulty", "information", "instructions", "sterispharma", "sterisonline", "bladder neck", "urinary symptoms", "nasal congestion", "frequent urination", "Common side effects", "healthcare professional", "persistent side effects", "benign prostatic hyperplasia", "alpha-1 adrenergic receptor antagonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1691, "imageuri": "https://productimages.withfloats.com/actual/667d3a5bc303c6d6ad1378fc.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3a5bc303c6d6ad1378fc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T11:55:28.528Z", "updatedon": "2026-03-17T06:35:00.624Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//silodosia-8/1691", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SILODOSIA 8", "category": "UROLOGYRANGE", "tags": [ "SILODOSIA 8 mg", "Silodosin (8mg)", "silodosin (8mg) + dutasteride (0.5mg)", "silodosin 8mg dosage", "silodosin 8mg side effects", "silodosin 8mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666e90fc193a21524676278", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA 8 TABS", "description": "SILODOSIA 8 TABS\nSilodosin (8mg)\nSilodosia 8 Tabs contain Silodosin, an alpha-1 adrenergic receptor antagonist used to treat symptoms of benign prostatic hyperplasia (BPH). Here’s a concise description:\n\nPurpose: Silodosia 8 Tabs are prescribed to alleviate symptoms associated with BPH, such as urinary frequency, urgency, and difficulty in urination.\nMechanism of Action: Silodosin works by relaxing the muscles in the prostate and bladder neck, thus improving urine flow and reducing symptoms.\nDosage: The standard dosage is 8mg once daily, preferably taken with food to enhance absorption.\nSide Effects: Common side effects may include dizziness, headache, nasal congestion, and decreased semen volume. Inform your doctor if these effects persist or worsen.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/silodosia-8-tabs-134359", "price": 233.0, "discountamount": 70.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "8mg", "BPH", "food", "Call", "Email", "ORDER", "Action", "doctor", "muscles", "Purpose", "urgency", "WhatsApp", "prostate", "headache", "symptoms", "Mechanism", "Silodosin", "dizziness", "urination", "absorption", "urine flow", "difficulty", "information", "sterispharma", "sterisonline", "semen volume", "bladder neck", "standard dosage", "SILODOSIA 8 TABS", "nasal congestion", "urinary frequency", "concise description", "Common side effects", "benign prostatic hyperplasia", "alpha-1 adrenergic receptor antagonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1690, "imageuri": "https://productimages.withfloats.com/actual/667d3ae4c303c6d6ad137996.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3ae4c303c6d6ad137996.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T11:52:47.796Z", "updatedon": "2026-03-17T06:35:12.583Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//silodosia-8-tabs/1690", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SILODOSIA 8 TABS", "category": "UROLOGYRANGE", "tags": [ "SILODOSIA 8 TABS", "Silodosin 8mg price", "Silodosin (8mg)", "Silodosin (8mg)", "Silodosin (8mg)", "Silodosin (8mg)" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666e7cd1b307e1a84142857", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA 4D", "description": "SILODOSIA 4D\nSilodosin (4mg), Dutasteride (0.5mg)\nSilodosia 4D combines Silodosin at 4mg and Dutasteride at 0.5mg for prostate health. Silodosin helps relax the muscles in the prostate and bladder neck, improving urine flow. Dutasteride reduces DHT levels, shrinking the prostate and relieving symptoms of BPH. This combination is effective in managing urinary symptoms and promoting prostate health. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/silodosia-4d-133506", "price": 259.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "4mg", "BPH", "Call", "0.5mg", "ORDER", "Email", "muscles", "WhatsApp", "Silodosin", "urine flow", "DHT levels", "Dutasteride", "combination", "information", "sterispharma", "bladder neck", "SILODOSIA 4D", "sterisonline", "prostate health", "urinary symptoms" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1689, "imageuri": "https://productimages.withfloats.com/actual/667d3b37000f6c164f096379.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3b37000f6c164f096379.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T11:47:25.826Z", "updatedon": "2026-03-17T06:31:16.478Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//silodosia-4d/1689", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SILODOSIA 4D", "category": "UROLOGYRANGE", "tags": [ "SILODOSIA 4D", "Silodosin 4mg", "Silodosin 4 mg uses", "Silodosin side effects", "Silodosin 8 mg uses", "Silodosin 4 mg Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666e70833ebd40c046ca05b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA 4", "description": "SILODOSIA 4\nSilodosin (4mg)\nSilodosia 4 contains Silodosin in 4mg strength. Silodosin is an alpha-1 adrenergic receptor antagonist used to treat symptoms of benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, improving urine flow and reducing symptoms like frequent or difficult urination.\n\nMedication Name: Silodosia 4\nActive Ingredient: Silodosin (4mg)\nMedical Use: Treats symptoms of benign prostatic hyperplasia (BPH)\nMechanism of Action: Blocks alpha-1 adrenergic receptors, relaxing prostate and bladder neck muscles\nDosage Strength: 4mg\nAdministration: Oral, usually once daily\nCommon Side Effects: Dizziness, headache, retrograde ejaculation\nPrecautions: Caution in patients with low blood pressure or liver problems\nContraindications: Avoid in patients with severe kidney impairment or allergy to Silodosin\nInteractions: May interact with blood pressure medications, caution with other alpha-blockers\nSilodosia 4 is generally well-tolerated but should be used with caution in certain patient populations. Always follow your healthcare provider's instructions for proper use and dosage. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/silodosia-4-133504\n\n\n\n\n\n\n", "price": 159.0, "discountamount": 48.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BPH", "Call", "Email", "ORDER", "Action", "allergy", "headache", "WhatsApp", "symptoms", "prostate", "patients", "frequent", "Mechanism", "SILODOSIA", "Dizziness", "Silodosin", "urine flow", "proper use", "Precautions", "information", "Medical Use", "instructions", "sterispharma", "sterisonline", "4mg strength", "liver problems", "Medication Name", "Contraindications", "Active Ingredient", "low blood pressure", "4mg Administration", "Common Side Effects", "healthcare provider", "patient populations", "difficult urination", "other alpha-blockers", "retrograde ejaculation", "severe kidney impairment", "blood pressure medications", "benign prostatic hyperplasia", "alpha-1 adrenergic receptors", "bladder neck muscles Dosage Strength", "alpha-1 adrenergic receptor antagonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1688, "imageuri": "https://productimages.withfloats.com/actual/667d3b665443982e2f655623.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3b665443982e2f655623.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T11:44:08.141Z", "updatedon": "2026-03-17T06:32:12.846Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//silodosia-4/1688", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SILODOSIA 4", "category": "UROLOGYRANGE", "tags": [ "SILODOSIA 4", "Silodosin 4mg", "", "Silodosin 4 mg uses", "Silodosin 4 mg dosage", "", "", "Silodosin side effects", "Silodosin 4 mg Uses in Hindi", "Silodosin 4 mg Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }